NDC 70710-1464-01 - Haloperidol decanoate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1464
- Requested NDC
- 70710-1464-01
- Package NDCs from labels
- 70710-1464-1, 70710-1464-5, 70710-1464-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2026-07-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HALOPERIDOL - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2026-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1464-1 | Haloperidol decanoate | 1 in 1 CARTON | INJECTION | 1 | 9 | |
| 70710-1464-1 | Haloperidol decanoate | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION | 5 | 9 | |
| 70710-1464-5 | Haloperidol decanoate | 5 in 1 CARTON | INJECTION | 5 | 9 | |
| 70710-1464-5 | Haloperidol decanoate | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION | 5 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1464 | HALOPERIDOL DECANOATE INJECTION [ZYDUS PHARMACEUTICALS USA INC.] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250215_6d2d7612-ad47-4ee7-a42c-945c976d947b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1464-1 | ML - Milliliter | 70710-1464 | 3bada281-20b2-4459-85bc-5c293ff9c1d8 | 1 | 2020-02-13 |
| 70710-1464-5 | ML - Milliliter | 70710-1464 | 8d4b58ad-aee2-48fa-aab7-6261573a4312 | 1 | 2020-02-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Lidocaine Plus Pain Relieving | LIDOCAINE HYDROCHLORIDE, BENZYL ALCOHOL | NATURAL ESSENTIALS, INC. | 1adb9b74-4a01-4461-b845-f3aedcb3f810 | 2024-10-01 | Warnings | LKG8494WBH |
| Ivarest | ZINC OXIDE, BENZYL ALCOHOL, AND DIPHENHYDRAMINE HYDROCHLORIDE | Blistex Inc | 6f68cbbb-6269-4bb3-8cc9-50b146703b42 | 2024-07-09 | Warnings | LKG8494WBH |
| Walgreens Lidocaine Plus Cream | BENZYL ALCOHOL AND LIDOCAINE HYDROCHLORIDE | Walgreens Company | e33e0097-31d6-8083-e053-2a95a90af5d2 | 2024-05-09 | Warnings | LKG8494WBH |
| HealthWise Lidocaine Plus Cream | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | Veridian Healthcare | 16f26249-b508-2c6e-e063-6394a90a265b | 2024-04-25 | Warnings | LKG8494WBH |
| haloperidol decanoate | HALOPERIDOL DECANOATE | Sagent Pharmaceuticals | b3167043-585f-482f-b8a7-591bc2721bd3 | 2024-02-27 | Boxed warning, Warnings, Adverse reactions | 1719862 1719803 859871 AC20PJ4101 |
| HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | Somerset Therapeutics, LLC | f2bff27f-929f-4f7d-b3eb-084ebc2a885f | 2023-12-18 | Boxed warning, Warnings, Adverse reactions | 859867 1719862 1719803 859871 AC20PJ4101 |
| CVS Maximum Strength LIDOCAINE PLUS | BENZYL ALCOHOL, LIDOCAINE HYDROCHLORIDE | CVS Pharmacy Inc. | e6aff579-affb-41bb-8e36-53ea484cb0c5 | 2023-11-26 | Warnings | LKG8494WBH |
| Bone Liquescence | TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE, CALCAREA MURIATICA, EQUISETUM ARVENSE, JUGLANS NIGRA, SESAME OIL, CALCAREA SULPHURICA, HEPAR SUIS, KIDNEY (SUIS), MEDULLA OSSIS SUIS, MENADIONE, THYROIDINUM (BOVINE), VITAMIN A, VITAMIN D3, CALCAREA PHOSPHORICA, CALCAREA CARBONICA, CALCAREA FLUORICA, MANGANUM METALLICUM, NICCOLUM METALLICUM, MAGNESIUM METALLICUM | Nutritional Specialties, Inc. | 5d323e16-e9a5-4933-9593-285c7b3c54ce | 2023-11-17 | Warnings | QX10HYY4QV |
| HALOPERIDOL DECANOATE | HALOPERIDOL DECANOATE | BluePoint Laboratories | f2d14406-2ad4-4c5b-9c24-a026f27b415d | 2023-09-11 | Boxed warning, Warnings, Adverse reactions | 1719862 1719803 859871 AC20PJ4101 |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | LKG8494WBH |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | LKG8494WBH |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | LKG8494WBH |
| Haloperidol decanoate | HALOPERIDOL DECANOATE | Zydus Lifesciences Limited | d21796e5-9f29-4c0a-8eed-70aeb9f0e5e9 | 2023-09-01 | ANDA211180 859867 1719862 1719803 859871 AC20PJ4101 | |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Fresenius Kabi USA, LLC | 262456c4-47e5-4713-8379-844f8f587495 | 2021-11-22 | Boxed warning, Warnings, Adverse reactions | 1719803 859871 AC20PJ4101 |
| Haloperidol Decanoate | HALOPERIDOL DECANOATE | Fresenius Kabi USA, LLC | ca9896e0-fb2e-46a4-8700-20d144c14764 | 2021-09-03 | Boxed warning, Warnings, Adverse reactions | 859867 1719862 1719803 859871 AC20PJ4101 |
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | LKG8494WBH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.